Eckert & Ziegler Soars with 17% Sales Jump, 41% EBIT Rise in Q1; 2024 Forecast Affirmed

• Sales increased by 17% to €67.6 million in Q1 2024 compared to the previous year
• EBIT before special items rose by 41% to €15.0 million in Q1 2024
• Net income increased to €8.5 million in Q1 2024
• Forecast for FY 2024 includes sales of just under €265 million and EBIT of around €50 million
• Sales in the Medical segment were 43% higher in Q1 2024 compared to the previous year
• Isotope Products segment generated external sales of €33.1 million in Q1 2024, slightly lower than the previous year but with shifts towards higher-margin products

The next important date, Publication of quarterly financial report (as of Q1), at Eckert & Ziegler is on 14.05.2024.

The price of Eckert & Ziegler at the time of the news was 40,05EUR and was up +0,50 % compared with the previous day.
15 minutes after the article was published, the price was 39,43EUR this corresponds to a minus of -1,55 % since publication.
At this time, the index SDAX was at 14.872,79PKT (+0,24 %).

Eckert & Ziegler

-0,37 %

+7,55 %

+22,13 %

+25,38 %

+19,88 %

-47,52 %

+96,21 %

+611,86 %

+1.078,83 %

ISIN:DE0005659700WKN:565970

• Intraday
• 5 Tage
• 1 Monat
• 3M
• 1 Jahr
• 3J
• 5J
• 10J
• Max